The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...
Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...
Haploid Technologies has developed a groundbreaking new technology that enables precise assignment of phase across multiple ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
Evaluating the Khorana score in advanced EGFR-mutated NSCLC patients receiving first-line osimertinib. Nimotuzumab plus chemotherapy in the posterior-line treatment for lung adenocarcinoma with ...
Brian Tait calls for public support to fund exciting groundbreaking technology for assigning phase to multiple mutations ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, and several distinguished researchers will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results